Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- PROMOTE-PIsIndependent statistical analysis of Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00993031).
- Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment: Complete Statistical AnalysisIndependent statistical analysis of Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02155946).
- Promoting Altruism to Enhance Vaccine Acceptance: Complete Statistical AnalysisIndependent statistical analysis of Promoting Altruism to Enhance Vaccine Acceptance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04568590).
- Promoting Cervical Cancer Screening for Emergency Department Patients: Complete Statistical AnalysisIndependent statistical analysis of Promoting Cervical Cancer Screening for Emergency Department Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03483610).
- Promoting Healthy Lifestyle Behaviors: Complete Statistical AnalysisIndependent statistical analysis of Promoting Healthy Lifestyle Behaviors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05675020).
- Promoting Physical Activity in Churchgoing Latinas: Complete Statistical AnalysisIndependent statistical analysis of Promoting Physical Activity in Churchgoing Latinas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01776632).
- Promoting Physical Activity in Rural Communities: Complete Statistical AnalysisIndependent statistical analysis of Promoting Physical Activity in Rural Communities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03683173).
- Promoting Physical Growth and Positive Development in Severely Stunted Guatemalan Children: Complete Statistical AnalysisIndependent statistical analysis of Promoting Physical Growth and Positive Development in Severely Stunted Guatemalan Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Promoting Resilience to Food Commercials Decreases Susceptibility to Unhealthy Food Decision-Making: Complete Statistical AnalysisIndependent statistical analysis of Promoting Resilience to Food Commercials Decreases Susceptibility to Unhealthy Food Decision-Making: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Promoting Stretching Exercise to Reduce Cardiovascular Health Risk in Late Pregnant Women With Obesity: Complete Statistical AnalysisIndependent statistical analysis of Promoting Stretching Exercise to Reduce Cardiovascular Health Risk in Late Pregnant Women With Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Promotion of Physical Activity in Adolescents With Intellectual and Developmental Disabilities: Complete Statistical AnalysisIndependent statistical analysis of Promotion of Physical Activity in Adolescents With Intellectual and Developmental Disabilities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ProMRI Study of the Entovis Pacemaker System: Complete Statistical AnalysisIndependent statistical analysis of ProMRI Study of the Entovis Pacemaker System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01761162).
- PROMUS Element Plus US Post-Approval Study: Complete Statistical AnalysisIndependent statistical analysis of PROMUS Element Plus US Post-Approval Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01589978).
- PROMUS PREMIER™ China Post-Approval Study: Complete Statistical AnalysisIndependent statistical analysis of PROMUS PREMIER™ China Post-Approval Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03273023).
- Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial: Complete Statistical AnalysisIndependent statistical analysis of Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02276885).
- PRONOUNCEDIndependent statistical analysis of 68Ga-THP-PSMA PET/CT Imaging in High Risk Primary Prostate Cancer or Biochemical Recurrence of Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PRONTOIndependent statistical analysis of The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis: primary endpoint results, effect estimate with confidence interval, sample-size…
- PRONTO-PBCIndependent statistical analysis of Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PRONTO-PumpIndependent statistical analysis of A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes: primary endpoint results, effect estimate with…
- PRONTO-T1DIndependent statistical analysis of A Study of LY900014 in Participants With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03214367).
- PRONTO-T2DIndependent statistical analysis of A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis: Complete Statistical AnalysisIndependent statistical analysis of Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression: Complete Statistical AnalysisIndependent statistical analysis of Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PROPELIndependent statistical analysis of BAX 855 PK-guided Dosing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02585960).
- PropelIndependent statistical analysis of Alveolar Microperforation for Inflammation-Enhanced Tooth Movement During Orthodontic Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01720797).
- PROPELIndependent statistical analysis of Promoting Successful Weight Loss in Primary Care in Louisiana: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02561221).
- Propel Stent vs Kenalog-soaked Nasopore After Frontal Drill-out: Complete Statistical AnalysisIndependent statistical analysis of Propel Stent vs Kenalog-soaked Nasopore After Frontal Drill-out: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03534362).
- Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05719285).
- Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00550290).
- Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size…
- Prophylactic Efficacy of Relenza Against Influenza A and B: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Efficacy of Relenza Against Influenza A and B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01156701).
- Prophylactic Ivermectin in COVID-19 Contacts: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Ivermectin in COVID-19 Contacts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04422561).
- Prophylactic Methylergonovine for Twin Cesarean: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Methylergonovine for Twin Cesarean: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05772156).
- Prophylactic nCPAP Following Bowel Surgery (Bio-REB File 11-27): Complete Statistical AnalysisIndependent statistical analysis of Prophylactic nCPAP Following Bowel Surgery (Bio-REB File 11-27): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01316575).
- Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02684344).
- Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study: Complete Statistical AnalysisIndependent statistical analysis of Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A: Complete Statistical AnalysisIndependent statistical analysis of Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Propofol and Dexmedetomidine Versus a Propofol Only Regimen for Sedation During Colonoscopy: Complete Statistical AnalysisIndependent statistical analysis of Propofol and Dexmedetomidine Versus a Propofol Only Regimen for Sedation During Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Propofol Versus Alfentanil Versus Nitrous Oxide for Moderate Procedural Sedation: Complete Statistical AnalysisIndependent statistical analysis of Propofol Versus Alfentanil Versus Nitrous Oxide for Moderate Procedural Sedation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00997126).
- PROPPERIndependent statistical analysis of PROPPER Prospective Registry of Outcomes With Penile Prosthesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01383018).
- Propranolol Dose Escalation in Lymphedema in Patients: Complete Statistical AnalysisIndependent statistical analysis of Propranolol Dose Escalation in Lymphedema in Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02595996).
- Propranolol for Challenging Behaviors in Autism: Complete Statistical AnalysisIndependent statistical analysis of Propranolol for Challenging Behaviors in Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04047355).
- Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas: Complete Statistical AnalysisIndependent statistical analysis of Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00967226).
- Proprioception of the Knee Post MIS TKA and MIS-QS TKA: Complete Statistical AnalysisIndependent statistical analysis of Proprioception of the Knee Post MIS TKA and MIS-QS TKA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02160977).
- ProQuad Dose Selection Study (V221-011)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of ProQuad Dose Selection Study (V221-011)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00986232).
- PROSAIndependent statistical analysis of Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03051620).
- PROSEEK: A Phase 2 Study In Early Parkinson’s Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706: Complete Statistical AnalysisIndependent statistical analysis of PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706: primary endpoint results, effect estimate with…
- PROSESIndependent statistical analysis of Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04820673).